| The role of ultrasonographic findings to predict molecular subtype, histologic grade, and hormone receptor status of breast cancer F Çelebi, KN Pilancı, Ç Ordu, F Ağacayak, G Alço, S İlgün, D Sarsenov, ... Diagnostic and Interventional Radiology 21 (6), 448, 2015 | 94 | 2015 |
| Impact of personality traits, anxiety, depression and hopelessness levels on quality of life in the patients with breast cancer F İzci, Zİ Erdogan, AS İlgün, E Çelebi, G Alço, N Kocaman, Ç Ordu, ... European journal of breast health 14 (2), 105, 2018 | 68 | 2018 |
| Role of increased mean platelet volume (MPV) and decreased MPV/platelet count ratio as poor prognostic factors in lung cancer M Omar, O Tanriverdi, S Cokmert, E Oktay, O Yersal, KN Pilancı, ... The clinical respiratory journal 12 (3), 922-929, 2018 | 57 | 2018 |
| Clinical and histopathological factors associated with Ki-67 expression in breast cancer patients GUL Alco, A Bozdogan, D Selamoglu, KN Pilancı, S Tuzlalı, C Ordu, ... Oncology letters 9 (3), 1046-1054, 2015 | 49 | 2015 |
| Preoperative lymphedema-related risk factors in early-stage breast cancer ZE Iyigun, T Duymaz, AS Ilgun, G Alco, C Ordu, D Sarsenov, AE Aydin, ... Lymphatic research and biology 16 (1), 28-35, 2018 | 44 | 2018 |
| Bioelectrical impedance for detecting and monitoring lymphedema in patients with breast cancer. Preliminary results of the florence nightingale breast study group Z Erdogan Iyigun, D Selamoglu, G Alco, KN Pilancı, C Ordu, F Agacayak, ... Lymphatic research and biology 13 (1), 40-45, 2015 | 40 | 2015 |
| Prognostic significance of the baseline serum uric acid level in non-small cell lung cancer patients treated with first-line chemotherapy: a study of the Turkish Descriptive … O Tanriverdi, S Cokmert, E Oktay, KN Pilanci, S Menekse, M Kocar, ... Medical Oncology 31, 1-7, 2014 | 39 | 2014 |
| Vitamin D levels in patients with breast cancer: importance of dressing style G Alco, S Igdem, M Dincer, V Ozmen, S Saglam, D Selamoglu, Z Erdogan, ... Asian Pacific Journal of Cancer Prevention 15 (3), 1357-1362, 2014 | 35 | 2014 |
| Pretreatment serum albumin level is an independent prognostic factor in patients with stage IIIB non-small cell lung cancer: a study of the Turkish descriptive oncological … O Tanriverdi, N Avci, E Oktay, S Kalemci, KN Pilanci, S Cokmert, ... Asian Pac J Cancer Prev 16 (14), 5971-5976, 2015 | 33 | 2015 |
| Synchronous and metachronous bilateral breast cancer: A long-term experience A Öztürk, G Alço, D Sarsenov, S İlgün, C Ordu, Ü Köksal, KN Pilancı, ... Imprimatur Publications, 2018 | 31 | 2018 |
| D-dimer and international normalized ratio (INR) are correlated with tumor markers and disease stage in colorectal cancer patients L Kilic, I Yildiz, FK Sen, MG Erdem, M Serilmez, S Keskin, R Ciftci, ... Cancer Biomarkers 15 (4), 405-411, 2015 | 31 | 2015 |
| Smoking habits are an independent prognostic factor in patients with lung cancer N Avci, M Hayar, O Altmisdortoglu, O Tanriverdi, A Deligonul, C Ordu, ... The Clinical Respiratory Journal 11 (5), 579-584, 2017 | 30 | 2017 |
| Usefulness of imaging findings in predicting tumor-infiltrating lymphocytes in patients with breast cancer F Çelebi, F Agacayak, A Ozturk, S Ilgun, M Ucuncu, ZE Iyigun, Ç Ordu, ... European Radiology 30, 2049-2057, 2020 | 29 | 2020 |
| Current adjuvant treatment modalities for gastric cancer: from history to the future L Kilic, C Ordu, I Yildiz, F Sen, S Keskin, R Ciftci, KN Pilanci World journal of gastrointestinal oncology 8 (5), 439, 2016 | 29 | 2016 |
| The role of elastography in diagnosis and staging of breast cancer-related lymphedema Z Erdogan Iyigun, F Agacayak, AS Ilgun, F Elbuken Celebi, C Ordu, ... Lymphatic research and biology 17 (3), 334-339, 2019 | 27 | 2019 |
| Is administration of trastuzumab an independent risk factor for developing osteonecrosis of the jaw among metastatic breast cancer patients under zoledronic acid treatment? KN Pilanci, G Alco, C Ordu, D Sarsenov, F Celebi, Z Erdogan, F Agacayak, ... Medicine 94 (18), e671, 2015 | 25 | 2015 |
| Development of acute pulmonary hypertension after bortezomib treatment in a patient with multiple myeloma: a case report and the review of the literature C Akosman, C Ordu, E Eroglu, B Oyan American journal of therapeutics 22 (3), e88-e92, 2015 | 23 | 2015 |
| Roles of biopsychosocial factors in the development of breast cancer M Özkan, N Yıldırım, R Dişçi, AS İlgün, D Sarsenov, G Alço, F Aktepe, ... European journal of breast health 13 (4), 206, 2017 | 21 | 2017 |
| Receptor discordance rate and its effects on survival in primary and recurrent breast cancer patients S İlgün, D Sarsenov, Z Erdoğan, C Ordu, F Celebi, KN Pilancı, A Özturk, ... Journal of Buon, 2016 | 20 | 2016 |
| Chronomodulated oxaliplatin plus Capecitabine (XELOX) as a first line chemotherapy in metastatic colorectal cancer: A Phase II Brunch regimen study KN Pilancı, S Saglam, A Okyar, S Yucel, Z Pala-Kara, C Ordu, E Namal, ... Cancer chemotherapy and pharmacology 78, 143-150, 2016 | 19 | 2016 |
Vahit Ozmen, Ozmen VIstanbul Medical Faculty Department of Surgery在 istanbul.edu.tr 的电子邮件经过验证
